Papers: 10.3390/cancers13133362

https://doi.org/10.3390/cancers13133362

TP53 Mutation as a Prognostic and Predictive Marker in Sarcoma: Pooled Analysis of MOSCATO and ProfiLER Precision Medicine Trials

Cited by: 5
Author(s): Elise F. Nassif, Édouard Auclin, Rastilav Bahleda, Charles Honoré, Olivier Mir, Sarah Dumont, Benoîte Méry, Khalil Hodroj, Mehdi Brahmi, Olivier Trédan, Isabelle Ray‐Coquard, Jean‐Yves Blay, Christophe Massard, Axel Le Cesne, Armelle Dufresne
Published: about 4 years ago

Software Mentions 3